title: Topiramate induced bilateral angle-closure glaucoma: low dosage in a short time.
abstract: OBJECTIVE
  The aim of this article is to create awareness among medical colleagues regarding the severe ophthalmic side effects associated with topiramate use.
  
  
  METHODS
  A case of severe acute bilateral angle closure glaucoma with visual blurring after oral topiramate therapy.
  
  
  RESULTS
  This case was successfully managed by discontinuing topiramate and by starting anti-glaucoma medication. Intraocular pressure, acute transient myopia, and anterior chamber depth were normalized.
  
  
  CONCLUSIONS
  It is important for clinicians to recognize these conditions and educate patients about these serious adverse effects when prescribing topiramate.
authors.affiliation: Department of Ophthalmology, Van State Hospital, Van, Turkey. acemidoktor@hotmail.com
authors.forename: Cagatay
authors.initials: C
authors.lastname: Caglar
authors.forename: Tekin
authors.initials: T
authors.lastname: Yasar
authors.forename: Dogan
authors.initials: D
authors.lastname: Ceyhan
mesh_terms: D000328:Adult; D005260:Female; D005632:Fructose / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015812:Glaucoma, Angle-Closure / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008881:Migraine Disorders / Q000517:prevention & control; D000077236:Topiramate; D016896:Treatment Outcome; D014792:Visual Acuity / Q000187:drug effects
chemical_list: D000077236:Topiramate; D005632:Fructose